- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
New Anticoagulants for Atrial Fibrillation ; volume:35 ; number:05 ; year:2009 ; pages:515-524
Seminars in thrombosis and hemostasis ; 35, Heft 05 (2009), 515-524
- Contributor
-
Sobieraj-Teague, Magdalena
O’Donnell, Martin
Eikelboom, John
- DOI
-
10.1055/s-0029-1234147
- URN
-
urn:nbn:de:101:1-2019030210115857768695
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Sobieraj-Teague, Magdalena
- O’Donnell, Martin
- Eikelboom, John
Other Objects (12)
New Anticoagulants for Atrial Fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Risk for osteoporotic fractures in patients with atrial fibrillation using different oral anticoagulants
Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis
Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
New Anticoagulants for Atrial Fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Risk for osteoporotic fractures in patients with atrial fibrillation using different oral anticoagulants
Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis
Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation
Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
New Anticoagulants for Atrial Fibrillation
Anticoagulants for Stroke Prevention in Atrial Fibrillation in Elderly Patients
Prevalence of atrial fibrillation and reasons for undertreatment with oral anticoagulants
Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
Direct Oral Anticoagulants in Atrial Fibrillation: Practical Considerations and Remaining Issues
Risk for osteoporotic fractures in patients with atrial fibrillation using different oral anticoagulants
Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis
Improving the Prescription of Oral Anticoagulants in Atrial Fibrillation: A Systematic Review
Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
Non-Vitamin K Oral Anticoagulants for Stroke Prevention in Special Populations with Atrial Fibrillation
Outcomes of left atrial appendage occlusion vs. non-vitamin K antagonist oral anticoagulants in atrial fibrillation